MERCK KGAA

The global peptone market is projected to grow from USD 846.4 million in 2024 to USD 1,299.0 million by 2034, driven by demand in biotechnology, biopharmaceuticals, and food industries. Key growth drivers include the expanding biotechnology sector, growing biopharmaceutical industry, and applications in the food industry. Market trends include a shift toward plant-based peptones and technological advancements in production.

The global Small Molecule Drug Discovery Market is growing due to outsourcing to CROs and increased R&D in the pharmaceutical industry. The market is expected to reach $106.77 billion by 2031 from $50.93 billion in 2023 at a CAGR of 9.7%. Key players include Bristol-Myers Squibb, Merck, GSK, Boehringer Ingelheim, Thermo Fisher Scientific, ICON, Danaher, Charles River Laboratories, Oncodesign Services, and Revvity Inc.

The global Apoptosis market is projected to grow from $5.4B in 2023 to $7.4B by 2030, driven by advances in molecular biology, AI integration, and personalized medicine. Key segments like Apoptosis Assay Kits and Reagents are expected to grow significantly, with the U.S. and China leading regional markets.

The drug discovery technologies market is projected to grow from $66.08 billion in 2023 to $108.31 billion by 2028, driven by advancements in genomic research, AI, and precision medicine. Key trends include AI integration, 3D cell culture, and blockchain for data security. Market drivers include the rising prevalence of chronic diseases and the development of advanced technologies by companies like Google.

SkyQuest projects the Global Preparative and Process Chromatography Market to reach USD 24.15 Billion by 2031, driven by increasing demand for monoclonal antibodies and advanced purification techniques. North America leads due to growing pharmaceutical and biotech industries.

The Life Science Reagents Market is projected to grow from USD 55.3 billion in 2022 to USD 92.2 billion by 2032, driven by advancements in biotechnology, molecular biology, and diagnostics. Key growth drivers include the adoption of personalized medicine, increased R&D investment, and the rising prevalence of chronic diseases. Challenges include stringent regulations, high costs, and a shortage of skilled professionals. Opportunities lie in the expansion of biopharmaceutical sectors, emerging markets, and technological advancements in reagent solutions.

The Pharmaceutical & Biotechnology Environmental Monitoring Market 2024 report analyzes types (Monitoring Equipment, Media, Software, Microbiology Services), applications (Pharmaceutical Industry, Biotechnology Industry, Academic & Research Institutes), major players (Danaher Corporation, Thermo Fisher Scientific, Eurofins Sinensis, Lonza, Biomerieux, VAI, Cosasco, RMONI, Amphenol Advanced Sensors, Merck KGaA, Vaisal), and regional outlook, forecasting growth from 2024-2032.

SkyQuest projects the genetic toxicology testing market to reach USD 3.84 billion by 2031, driven by personalized medicine and genetic health improvement. Advances in genetic technologies and regulatory mandates are also contributing to market growth.

The Brain Tumor Therapeutics Market is projected to grow from USD 3.28 billion in 2024 to USD 5.28 billion by 2030, driven by advances in healthcare technologies and increased investment in oncology research. Key areas explored include market penetration, development, diversification, competitive assessment, and product innovation. Challenges include high R&D costs and regulatory hurdles. Opportunities lie in personalized medicine and novel drug delivery systems.

Cell Expansion Market to grow at 14.9% CAGR from USD 12.45 billion in 2023 to USD 43.44 billion in 2030, driven by chronic diseases and regenerative medicine. Key players include Thermo Fisher Scientific and Merck KGaA. Asia-Pacific expected to lead growth due to biotech investments.